IMS Company Profiles - Report Buyer

IMS COM PANY PRO FILES NOVARTIS SUBSIDIARY LISTING
anti rheu ma tics sys temic 11%
ophthalmologicals 9%
antineoplastics 7%
an al ge sics 5%
Lead ing Dose Forms:
coated tab lets 44%
tab lets 23%
liq uids 10%
cap sules 9%
am poules 5%
MEXICO
GERBER
Full Name: Productos Gerber, S.A. de C.V.
Postal Ad dress: Apartado Postal 98, Queretaro,
76000
Street Ad dress: Epigmenio Gon za lez No.59,
Colonia San Pablo, Queretaro, 76159
Tel: +52 442 211 83 00
Fax: +52 442 217 15 62
HEXAL
Full Name: Lab o ra to ries Hexal S.A. de C.V.
Street Ad dress: Calle Candelaria 186, Colonia
Atlantida, Delegacion Coyoacan, 04370 Mex ico
DF
Tel: +52 55 549 37 40
Fax: +52 55 544 05 81
Email: ser vice@hexal.com.mx
Home Page: www.hexal.com.mx
De scrip tion: Man u fac turer, dis trib u tor. Prod uct
ranges in clude: phar ma ceu ti cal prod ucts. Es tab -
lished 1998.
Con tacts (Pharm): Chair man: Jorge Alberto
Santos Quinonez
NOVARTIS
Full Name: Novartis Corporativo, S.A. de C.V.
Street Ad dress: Calzada Tlalpan No. 1779, Col.
San Diego Churubusco, Delegacion Coyoacan,
Mex ico DF, 04120
Tel: +52 55 542 087 00
Fax: +52 55 554 417 20
Email: con.tacto@pharma.novartis.com
Home Page: www.novartis.com.mx
De scrip tion: Dis trib utes, sells/de tails for other
com pa nies. Es tab lished 1996. Di vi sions in clude:
Novartis OTC.
Con tacts (Pharm): Com mer cial Op er a tions: Dr
Rolf Immler; Gen eral Con tact: Lic Je sus Origel
Sub sid iary of: Novartis, Swit zer land (100%)
Phar ma ceu ti cal Sales: US$ 230-240 mil lion
Prod ucts (% of Sales by Lead ing 5): 35-40%
Ther a peu tic Classes (% of Sales by Lead ing
5): 65-70%
Dose Forms (% of Sales by Lead ing 5):
90-95%
Prin ci pal Prod ucts:
CO-DIOVAN (an gio ten sin-II an tag o nist com bi na -
tion)
VOLTAREN (antirheumatic non-steroidal; oph -
thal mic anti-in flam ma tory non-steroidal)
DIOVAN (an gio ten sin-II an tag o nist plain)
CATAFLAM (antirheumatic non-steroidal;
antirheumatic top i cal)
TEGRETOL (antiepileptic)
Ther a peu tic Range:
anti rheu ma tics sys temic 22%
renin-an gio ten sin sys tem agents 20%
antiepileptics 11%
psychoanaleptics 7%
antifungals sys temic 5%
Lead ing Dose Forms:
coated tab lets 44%
tab lets 29%
liq uids 10%
cap sules 6%
am poules 3%
NOVARTIS GENERICS
Full Name: Novartis Farmaceutica, S.A. de C.V.
Street Ad dress: Augusto Ro din No.128, Col. San
Juan Mixcoac, Delegacion Benito Juarez, Mex ico
DF, 03730
Tel: +52 55 548 23 400
Fax: +52 55 561 53 797
Home Page: www.novartis.com.mx
De scrip tion: Es tab lished 1996.
Phar ma ceu ti cal Sales: US$ 80-85 mil lion
Prod ucts (% of Sales by Lead ing 5): 40-45%
Ther a peu tic Classes (% of Sales by Lead ing
5): 70-75%
Dose Forms (% of Sales by Lead ing 5):
95-100%
Prin ci pal Prod ucts:
BENZETACIL AP (pen i cil lin me dium/nar row spec -
trum)
MEGION (cephalosporin)
AVAPENA (an ti his ta mine sys temic)
LOPRESOR (beta-blocker agent plain)
AMLIBON (cal cium an tag o nist plain)
Ther a peu tic Range:
antibacterials sys temic 41%
© 2009 IMS Health In cor po rated or its af fil i ates Page 188